This study is seeking male participants who suffer from mild asthma.
Current therapies to treat asthma can have limited effect depending on the severity of the condition and thus there is a need for new treatment options. This drug is administered in the form of a mist inhaled into the lungs. It has already been tested as a single dose in healthy volunteers at the Centre for Clinical Studies and has been found to be well tolerated.
Participants will be paid for their time.
The current study schedule for the next group of this study is available here.